On the 31st May and 1st June 2023, the US-FDA in conjunction with HESI hosted a workshop on “Research Roadmap Planning on Hazard and Risk Assessment of Nitrosamine Impurities in Drugs” and the event was available as a webcast live on-line. Visit this link for more details.
